1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Exelixis, Inc.

Exelixis, Inc.

EXEL
Exelixis, Inc.US flagNASDAQ Global Select
62.68
USD
+0.45
- -
15.75BMarket Cap

Total Valuation

Exelixis, Inc. carries a market capitalization of 15.75B, placing it among publicly traded companies globally. Its enterprise value stands at 12.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap15.75B
Enterprise Value12.87B

Share Statistics

Exelixis, Inc. currently has 248.89M shares outstanding.

Shares Outstanding248.89M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Exelixis, Inc. trades at a trailing price-to-earnings ratio of 16.50. The price-to-sales ratio is 5.83, and the price-to-book ratio stands at 7.34.

PE Ratio16.50
PS Ratio5.83
PB Ratio7.34
P/TBV Ratio7.61
P/FCF Ratio12.18
P/OCF Ratio12.00

Enterprise Valuation

On an enterprise value basis, Exelixis, Inc. trades at an EV/EBITDA multiple of 12.61 and an EV/FCF ratio of 10.65. The EV/Sales ratio of 5.28 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.97 provides insight into valuation relative to core operating earnings.

EV / Sales5.28
EV / EBITDA12.61
EV / EBIT12.97
EV / FCF10.65

Financial Position

Exelixis, Inc. maintains a current ratio of 3.46, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.

Current Ratio3.46
Quick Ratio3.21
Debt / Equity9.00
Debt / EBITDA0.16
Interest CoverageN/A

Financial Efficiency

Exelixis, Inc. posts a return on equity of 44.39 and a return on invested capital of 39.05.

Return on Equity (ROE)44.39
Return on Assets (ROA)33.28
Return on Invested Capital (ROIC)39.05
Return on Capital Employed (ROCE)40.76
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.28

Taxes

Over the trailing twelve months, Exelixis, Inc. has paid 174.84M in income taxes, reflecting an effective tax rate of 16.89.

Income Tax174.84M
Effective Tax Rate16.89

Stock Price Statistics

Exelixis, Inc.'s stock has gained approximately 81.47076% over the past 52 weeks. The 50-day moving average sits at 56.96, while the 200-day moving average is 49.94.

Beta (5Y)N/A
52-Week Price Change81.47076%
50-Day Moving Average56.96
200-Day Moving Average49.94
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Exelixis, Inc. generated 2.44B in revenue and converted that into 860.62M in net income, yielding earnings per share of 3.18. EBITDA reached 1.02B, while operating income came in at 992.02M.

Revenue2.44B
Gross Profit2.35B
Operating Income992.02M
Pretax Income1.04B
Net Income860.62M
EBITDA1.02B
EBIT992.02M
Earnings Per Share (EPS)3.18

Balance Sheet

Exelixis, Inc. holds 839.39M in cash and equivalents against 165.93M in total debt, resulting in a net debt position of -281.45M. Total book value stands at 1.84B, with working capital of 888.90M providing operational flexibility.

Cash & Cash Equivalents839.39M
Total Debt165.93M
Net Debt-281.45M
Equity (Book Value)1.84B
Book Value Per Share7.41
Working Capital888.90M

Cash Flow

Exelixis, Inc. produced 1.18B in operating cash flow over the past twelve months. After subtracting -25.24M in capital expenditures, free cash flow totaled 1.16B - equivalent to 4.44 per share.

Operating Cash Flow1.18B
Capital Expenditures-25.24M
Free Cash Flow1.16B
FCF Per Share4.44

Margins

Exelixis, Inc. operates with a gross margin of 96.48, reflecting its pricing power and cost economics. The operating margin of 40.72 and net profit margin of 35.33 provide insight into operational efficiency.

Gross Margin96.48
Operating Margin40.72
Pretax Margin42.51
Profit Margin35.33
EBITDA Margin41.89

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield8.56
FCF Yield8.21

Scores

Exelixis, Inc. posts an Altman Z-Score of 15.13, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score15.13